139 related articles for article (PubMed ID: 20854905)
21. Determination of titanocene, a new drug with anticancer potential, and its metabolism in solution by capillary electrophoresis.
Wittrisch H; Schröer HP; Vogt J; Vogt C
Electrophoresis; 1998 Nov; 19(16-17):3012-7. PubMed ID: 9870405
[TBL] [Abstract][Full Text] [Related]
22. Analyses of Titanocenes in the spheroid-based cellular angiogenesis assay.
Weber H; Claffey J; Hogan M; Pampillón C; Tacke M
Toxicol In Vitro; 2008 Mar; 22(2):531-4. PubMed ID: 17981007
[TBL] [Abstract][Full Text] [Related]
23. Anticancer activity and mode of action of titanocene C.
Olszewski U; Claffey J; Hogan M; Tacke M; Zeillinger R; Bednarski PJ; Hamilton G
Invest New Drugs; 2011 Aug; 29(4):607-14. PubMed ID: 20162321
[TBL] [Abstract][Full Text] [Related]
24. Composite fiber structures with antiproliferative agents exhibit advantageous drug delivery and cell growth inhibition in vitro.
Kraitzer A; Kloog Y; Haklai R; Zilberman M
J Pharm Sci; 2011 Jan; 100(1):133-49. PubMed ID: 20623695
[TBL] [Abstract][Full Text] [Related]
25. NTP Toxicology and Carcinogenesis Studies of Titanocene Dichloride (CAS No. 1271-19-8) in F344/N Rats (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1991 Sep; 399():1-182. PubMed ID: 12637960
[TBL] [Abstract][Full Text] [Related]
26. The implantable 5-fluorouracil-loaded poly(l-lactic acid) fibers prepared by wet-spinning from suspension.
Gao H; Gu Y; Ping Q
J Control Release; 2007 Apr; 118(3):325-32. PubMed ID: 17321624
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of human topoisomerase I and II and anti-proliferative effects on MCF-7 cells by new titanocene complexes.
Chimento A; Saturnino C; Iacopetta D; Mazzotta R; Caruso A; Plutino MR; Mariconda A; Ramunno A; Sinicropi MS; Pezzi V; Longo P
Bioorg Med Chem; 2015 Nov; 23(22):7302-12. PubMed ID: 26526741
[TBL] [Abstract][Full Text] [Related]
28. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride.
Waern JB; Dillon CT; Harding MM
J Med Chem; 2005 Mar; 48(6):2093-9. PubMed ID: 15771451
[TBL] [Abstract][Full Text] [Related]
29. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas.
Köpf-Maier P
J Cancer Res Clin Oncol; 1987; 113(4):342-8. PubMed ID: 3036884
[TBL] [Abstract][Full Text] [Related]
30. Enhancement of the cytotoxicity of titanocene dichloride by aging in organic co-solvent.
Ravera M; Cassino C; Monti E; Gariboldi M; Osella D
J Inorg Biochem; 2005 Dec; 99(12):2264-9. PubMed ID: 16209887
[TBL] [Abstract][Full Text] [Related]
31. Electrospun fibers of acid-labile biodegradable polymers containing ortho ester groups for controlled release of paracetamol.
Qi M; Li X; Yang Y; Zhou S
Eur J Pharm Biopharm; 2008 Oct; 70(2):445-52. PubMed ID: 18603416
[TBL] [Abstract][Full Text] [Related]
32. BCNU-loaded PEG-PLLA ultrafine fibers and their in vitro antitumor activity against Glioma C6 cells.
Xu X; Chen X; Xu X; Lu T; Wang X; Yang L; Jing X
J Control Release; 2006 Sep; 114(3):307-16. PubMed ID: 16891029
[TBL] [Abstract][Full Text] [Related]
33. Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.
Korfel A; Scheulen ME; Schmoll HJ; Gründel O; Harstrick A; Knoche M; Fels LM; Skorzec M; Bach F; Baumgart J; Sass G; Seeber S; Thiel E; Berdel WE
Clin Cancer Res; 1998 Nov; 4(11):2701-8. PubMed ID: 9829732
[TBL] [Abstract][Full Text] [Related]
34. [The preparation of poly (DL-lactide) hollow fiber and the release of drug in vitro].
Zhu J; Shen Z; Ma Z; Wu L; Shi D
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 1997 Sep; 14(3):247-51. PubMed ID: 11326842
[TBL] [Abstract][Full Text] [Related]
35. Antitumour bis(cyclopentadienyl) metal complexes: titanocene and molybdocene dichloride and derivatives.
Abeysinghe PM; Harding MM
Dalton Trans; 2007 Aug; (32):3474-82. PubMed ID: 17680034
[TBL] [Abstract][Full Text] [Related]
36. A Monte Carlo evaluation of dose enhancement by cisplatin and titanocene dichloride chemotherapy drugs in brachytherapy with photon emitting sources.
Yahya Abadi A; Ghorbani M; Mowlavi AA; Knaup C
Australas Phys Eng Sci Med; 2014 Jun; 37(2):327-36. PubMed ID: 24706342
[TBL] [Abstract][Full Text] [Related]
37. Effects of titanocene dichloride derivatives on prostate cancer cells, specifically DNA damage-induced apoptosis.
Cuffe S; Dowling CM; Claffey J; Pampillón C; Hogan M; Fitzpatrick JM; Carty MP; Tacke M; Watson RW
Prostate; 2011 Feb; 71(2):111-24. PubMed ID: 20665530
[TBL] [Abstract][Full Text] [Related]
38. New titanocene derivatives with high antiproliferative activity against breast cancer cells.
Saturnino C; Sirignano E; Botta A; Sinicropi MS; Caruso A; Pisano A; Lappano R; Maggiolini M; Longo P
Bioorg Med Chem Lett; 2014 Jan; 24(1):136-40. PubMed ID: 24332626
[TBL] [Abstract][Full Text] [Related]
39. [Fabrication, characterization and drug release characteristics of drug loaded poly (L-lactic acid) fiber].
Gao H; Ping Q; Gu Y
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2008 Aug; 25(4):870-3. PubMed ID: 18788299
[TBL] [Abstract][Full Text] [Related]
40. Antitumor metallocenes: new developments and toxicologic features.
Köpf-Maier P; Köpf H
Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
